Clinical trial
Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
NCT00470054
Study timeline
Study start (unknown)2007-04-01Date precision: month
Registry last updated2015-05-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Extensive Stage Small Cell Lung Cancerunresolved
Limited Stage Small Cell Lung Cancerunresolved
Recurrent Small Cell Lung Cancerunresolved
Interventions
dasatinibDRUG · verified · RxNorm: dasatinib
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00470054 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.